Профилактическая медицина и здоровье 3-jild 3-son (2024) · 13-19-betlar
Evaluation of the effect of intravitreal injections of brolucizumab on ocular hemodynamics in patients with neovascular form of Age-related macular degeneration
Khairullayeva, Maftuna, Хайруллаева, Мафтуна, Xayrullayeva, Maftuna
Annotatsiya
Age-related macular degeneration (AMD) is a prevalent cause of blindness and visual impairment in individuals over 50 years of age in economically developed countries [2, 10]. The prevalence of AMD is 14.4% among those aged 55 to 64 years, 19.4% in individuals aged 65 to 74 years, and 36.8% in those over 75 years of age [1, 12]. The recent increase in life expectancy is contributing to the rising prevalence of this condition. AMD occurs in two forms: dry and wet. The wet or neovascular form is marked by choroidal neovascularization (CNV), which presents with various complications such as edema, detachment of the neuro- and pigment epithelium, hemorrhages, and exudates, ultimately leading to vision loss [5, 7].
возрастная макулярная дегенерациянеоваскулярная формаглазная гемодинамикабролуцизумабage-related macular degenerationneovascular formocular hemodynamicsbrolucizumabyoshga bog‘liq makula degeneratsiyasineovaskulyar shakl
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.